Mankind Pharma Under GST Department Inspection, Operations Continue Smoothly

Mankind Pharma Ltd, one of India’s leading pharmaceutical companies, has announced that a search and seizure operation was carried out by the GST Department at Bharat Serums and Vaccines from February 3 to February 8, 2026. The company emphasized that despite the inspection, unit operations continued without disruption, ensuring smooth functioning across facilities.  

The inspection forms part of routine regulatory oversight, aimed at ensuring compliance with tax and operational norms. Mankind Pharma highlighted that its business continuity remained unaffected, underscoring its commitment to transparency and adherence to statutory requirements.  

Analysts note that the company’s ability to maintain uninterrupted operations during such inspections reflects strong governance practices and operational resilience. The announcement reassures stakeholders of Mankind Pharma’s compliance-driven approach in a highly regulated industry.  

Key highlights from the announcement include  

• Search and seizure inspection conducted by GST Department  
• Operation carried out between February 3 and February 8, 2026  
• Unit operations continued as usual during inspection  
• Inspection conducted at Bharat Serums and Vaccines  
• Company reinforces compliance and operational resilience  

Industry experts emphasize that Mankind Pharma’s proactive communication signals confidence in its governance framework, reassuring investors and stakeholders of its long-term stability.  

Sources: Reuters, Economic Times, Business Standard